Both in R&D — Physical & Biological Sciences
IQVIA Holdings vs IB Acquisition
Over the past year IQV returned +20.8% and IBAC returned +3.6%; their daily moves had a correlation of -0.03.
IQV +20.8% IBAC +3.6%Growth of $1, one year, split-adjusted
| Metric | IQV | IBAC |
|---|---|---|
| Price | $262.59 | $10.81 |
| Market cap | $43.27B | $54.1M |
| Today | +1.61% | −0.46% |
| 1 month | −1.3% | −0.6% |
| 6 months | +48.8% | −0.2% |
| Year to date | +16.5% | +3.0% |
| 1 year | +21.3% | — |
| Revenue growth (YoY) | +8.0% | — |
| Gross margin | 33.8% | — |
| Net margin | 7.9% | — |
| P/E (TTM) | 31.0× | — |
| Price / sales | 2.5× | — |
| Net cash | -$13.64B | — |
| Dividend yield | — | — |
| Volatility (60d) | 26.8% | 20.1% |
| Short % of float | 2.0% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).